These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35883758)

  • 1. A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Gámez JM; Tejada S; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Abbate M; Montemayor S; Mascaró CM; Casares M; Tejada S; Abete I; Zulet MA; Tur JA; Martínez JA; Sureda A
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Argelich E; Casares M; Ugarriza L; Llompart I; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; Llompart I; Mateos D; Casares M; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Mateos D; Casares M; Gómez C; Ugarriza L; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Jun; 13(7):. PubMed ID: 39061823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés MM; Bouzas C; Pastor O; Ugarriza L; Llompart I; Cevallos-Ibarra K; Sureda A; Tur JA
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.
    Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A
    Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 18. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease.
    Javadi L; Khoshbaten M; Safaiyan A; Ghavami M; Abbasi MM; Gargari BP
    Asia Pac J Clin Nutr; 2018; 27(5):1031-1039. PubMed ID: 30272851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.